Dr. Reddy's Laboratories
169 hedge funds and large institutions have $1.12B invested in Dr. Reddy's Laboratories in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 23 closing their positions.
17% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 23
3.11% more ownership
Funds ownership: 73.05% → 76.17% (+3.1%)
2% more funds holding
Funds holding: 165 → 169 (+4)
4% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 53
3% more capital invested
Capital invested by funds: $1.09B → $1.12B (+$29.5M)
37% less call options, than puts
Call options by funds: $311K | Put options by funds: $496K
Top Buyers
Top Sellers
RDY Hedge Fund Activity: Q2 2014 in Review
169 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2014, worth a combined $1.12B — up 2.7% from $1.09B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new RDY positions and 23 closed out — a net gain of 4 holders — while 55 added to existing stakes and 53 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $61M. The largest seller was Ninety One (UK), exiting entirely with an estimated $22.1M sold.
- 169 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2014, up from 165 in Q1 2014.
- Funds reported $1.12B of Dr. Reddy's Laboratories stock for Q2 2014, up 2.7% quarter-over-quarter.
- 27 funds opened new Dr. Reddy's Laboratories positions in Q2 2014 and 23 closed out, a net change of +4 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2014 was Fisher Asset Management, an estimated $61M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2014 was Ninety One (UK), an estimated $22.1M sold.
Based on aggregated 13F filings for Q2 2014.